Evolution of the Average Target: West Pharmaceutical Services, Inc.

Evolution of the Average Target - West Pharmaceutical Services, Inc.

Evolution of the Target Price: West Pharmaceutical Services, Inc.

Evolution of the Target Price - West Pharmaceutical Services, Inc.

Changes in Analyst Recommendations: West Pharmaceutical Services, Inc.

e5cb2b2f1a92afad176d9d.dXCK7B3y68EegqtAI30HmGQ3p_YI25z9DnoeEO4ZJ_E.JT7wpEvCnoJ25P8YaQ9JyzZj1ZJxofKfVBFJSYlJTKMYH7uberSA-Vbq5g~184b96accc3afbda6c0f6a2ecfd68ea7
10-13 TD Cowen Adjusts Price Target on West Pharmaceutical Services to $420 From $410 MT
10-07 Evercore ISI Adjusts West Pharmaceutical Services Price Target to $440 From $410 MT
10-06 Barclays Raises West Pharmaceutical Services Price Target to $440 From $400, Maintains Overweight Rating MT
09-22 West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says MT
09-22 Morgan Stanley Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $365 MT
09-09 UBS Raises Price Target on West Pharmaceutical Services to $415 From $340, Keeps Buy Rating MT
07-27 Evercore ISI Adjusts PT on West Pharmaceutical Services to $425 From $410, Maintains Outperform Rating MT
07-27 BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating MT
07-24 Jefferies & Co Adjusts West Pharmaceutical Services PT to $410 From $365, Maintains Buy Rating MT
07-24 Rothschild & Co Redburn Adjusts West Pharmaceutical Services PT to $410 From $353, Maintains Buy Rating MT
07-24 Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $420 From $405, Maintains Buy Rating MT
07-20 Stephens Adjusts West Pharmaceutical Services Price Target to $410 From $360, Maintains Overweight Rating MT
07-15 TD Cowen Adjusts Price Target on West Pharmaceutical Services to $410 From $365, Maintains Buy Rating MT
07-13 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
07-13 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
07-09 Morgan Stanley Adjusts Price Target on West Pharmaceutical Services to $365 From $325 MT
07-06 Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $410 From $390 MT
07-02 KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating MT
06-09 Barclays Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $310 MT
05-28 Morgan Stanley Adjusts West Pharmaceutical Services PT to $325 From $315, Keeps Equalweight Rating MT
04-24 Stephens Adjusts Price Target on West Pharmaceutical Services to $360 From $320, Maintains Overweight Rating MT
04-24 Deutsche Bank Adjusts West Pharmaceutical Services PT to $340 From $315, Maintains Buy Rating MT
04-24 Rothschild & Co Redburn Adjusts West Pharmaceutical Services Price Target to $353 From $312, Maintains Buy Rating MT
04-24 Jefferies Adjusts West Pharmaceutical Services Price Target to $365 From $295, Maintains Buy Rating MT
04-24 Citigroup Adjusts West Pharmaceutical Services PT to $400 From $375, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+5.15%
+18.95%
+21.85%
+12.45%
+23.1%
+8.42%
+15.54%
+0.63%
+26.11%
+33.74%
Average +16.59%
Weighted average by Cap. +17.04%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
393.48USD
Average target price
413.73USD
Spread / Average Target
+5.15%
High Price Target
459.00USD
Spread / Highest target
+16.65%
Low Price Target
340.00USD
Spread / Lowest Target
-13.59%

Analyst Consensus Detail

Analyst consensus - West Pharmaceutical Services, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - West Pharmaceutical Services, Inc.
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - West Pharmaceutical Services, Inc.
  1. Stock Market
  2. Stocks
  3. WST Stock
  4. Consensus West Pharmaceutical Services, Inc.